Streetbeat News

Stock Prices

CRBU

Caribou Biosciences plans to offer $100M of its common stock in a public offering. The company also intends to grant underwriters a 30-day option to purchase up to an additional $15M of shares at the public offering price, less underwriting discounts and commissions. The completion and terms of the offering are subject to market and other conditions.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 8:04 pm

CYBR

CyberArk Software (NASDAQ:CYBR) has received positive analyst ratings in the last quarter, with 15 bullish and no bearish ratings. The average 12-month price target for the company is $180.67, which has increased by 2.65% over the past month.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:01 pm

ONON

Analysts have provided bullish and somewhat bullish ratings for On Holding (NYSE:ONON) in the last quarter. According to 10 analysts offering 12-month price targets in the last 3 months, On Holding has an average price target of $36.2, an increase of 2.84% from the previous average price target of $35.20.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:01 pm

THRX

Shares of Theseus Pharmaceuticals have been halted due to pending news.

Portfolio Pulse from Happy Mohamed

July 13, 2023 | 8:01 pm

CAMP

Over the past 3 months, 6 analysts have published their opinion on CalAmp (NASDAQ:CAMP) stock. The average price target is $2.46, representing a 48.54% decrease from the previous average price target of $4.78. The ratings include 2 bullish, 1 indifferent, and 3 bearish.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

SHW

Sherwin-Williams (NYSE:SHW) has outperformed the market over the past 10 years by 5.5% on an annualized basis, producing an average annual return of 15.86%. If an investor had bought $100 of SHW stock 10 years ago, it would be worth $436.90 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

CZR

Over the past 3 months, 5 analysts have published their opinion on Caesars Entertainment (NASDAQ:CZR) stock. The company has an average price target of $64.8, an increase of 8.91% from the previous average price target of $59.50. The analysts' ratings range from bullish to indifferent.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

DHR

Over the past 5 years, Danaher (NYSE:DHR) has outperformed the market by 9.18% on an annualized basis, producing an average annual return of 19.12%. If an investor had bought $100 of DHR stock 5 years ago, it would be worth $243.33 today.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

EFC

Analysts have provided somewhat bullish ratings for Ellington Financial (NYSE:EFC) in the last quarter. According to 5 analysts offering 12-month price targets in the last 3 months, Ellington Financial has an average price target of $13.8, a decrease of 1.99% from the previous average price target of $14.08.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

GDRX

GoodRx and CVS Caremark have announced the launch of Caremark Cost Saver, a program aimed at reducing pharmacy out-of-pocket drug costs for CVS Caremark clients' members. This news has led to an increase in GoodRx's share price.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 7:57 pm